SWOG clinical trial number
CTSU/EA2176

A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients

Open
Phase
Abbreviated Title
A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients
Activated
10/15/2020

Research committees

Gastrointestinal Cancer

Treatment

Carboplatin Nivolumab Paclitaxel